November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at email@example.com)
February 08, 2016
KREMLIN HOPES THAT UPCOMING MEETING BETWEEN PATRIARCH OF MOSCOW AND ALL RUSSIA AND POPE OF ROME WILL BE SUCCESSFUL - PESKOV
DIA could pay Intercommerz Bank shareholders 64.8 bln rubles
PESKOV: KREMLIN SEES UPCOMING MEETING BETWEEN PATRIARCH OF MOSCOW AND ALL RUSSIA AND POPE OF ROME AS 'A RECIPROCAL STEP TOWARDS' RUSSIA AND WESTERN WORLD
Kazakh president due to visit Iran in April
POSSIBLE GROUND OPERATION OF TURKEY, SAUDI ARABIA IN SYRIA IS AT ODDS WITH VIENNA AGREEMENTS OF INTERNATIONAL SYRIA SUPPORT GROUP - RUSSIAN AMBASSADOR TO SYRIA TELLS INTERFAX
Seven ISIL members preparing terror attacks in Moscow, St. Petersburg detained in Yekaterinburg - FSB
RUSSIAN AMBASSADOR TO DAMASCUS SAYS POSSIBILITY OF TURKISH INVASION IN SYRIA CANNOT BE RULED OUT AFTER ATTACK ON SU-24
Gen. Nazarzoda's mutiny participants, leaders of outlawed Islamic Renaissance Party to face court
Moscow interbank bid & offered rate
ISIL FIGHTER WHO ARRIVED FROM TERRITORY OF TURKEY WAS IN CHARGE OF ISLAMIST GROUP - FSB
ISLAMISTS DETAINED IN YEKATERINBURG PLANNED TO DEPART FOR SYRIA AFTER COMMITTING TERROR ATTACKS - FSB
SEVEN ISIL MEMBERS PREPARING TERROR ATTACKS IN MOSCOW AND ST. PETERSBURG DETAINED IN YEKATERINBURG
Vanino Port board replaces chairman
A1 president Vinokurov becomes controlling shareholder in pharma distributor SIA International - source